Nasopharyngeal Carcinoma In Phase II Trial - Bevacizumab Reduced Spread
Links shared publicly online about this topic.
- 0total visits
Nasopharyngeal Carcinoma In Phase II Trial - Bevacizumab Reduced Spread
A new phase II trial published Online First in The Lancet Oncology, reveals that the combination of standard chemoradiation therapy with the popular cancer drug bevacizumab is safe and may
View full resource at medicalnewstoday.com
Tags: Cancer, Cancer Medication, Colorectal Cancer Medication, Drug, Avastin, Oncology, Safety
Most Recently Shared on December 17, 2011 at 8:53 am By:
Nasopharyngeal Carcinoma In Phase II Trial - Bevacizumab Reduced Spread: A new phase II trial published Online F... http://t.co/cUktSUlP
Advertisement
